CEO: Leonard S. Schleifer

Sector: Health Technology
Industry:Biotechnology

Exchange: NASDAQ

Country: US

Description: Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.


Key numbers

Market Capitalization:71131888555
Shares Outstanding: 110673000
Float: 107646536
Next Earning Date:2020-08-05
TTm EPS: 20.8328
TTm Dividend Rate:
200 days moving average:464.68
50 days moving average: 611.29
One day percent Change: 0.5



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,